<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9446322" created="2007/05/30" creator="Maki Niihori"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9446322</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">[<term id="T1" lex="Molecular-biologic_aspect" sem="Other">Molecular-biologic aspects</term> of interaction between <cons id="T2" lex="(AND nervous_system immune_system)" sem="(AND Body_region Body_region)"><frag id="F1">nervous</frag> and <frag id="F2">immune</frag> <frag id="F3">systems</frag></cons>]</sentence>
<event KT="Investigation" id="E1" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="F1" idref1="F3"/>
<theme idref="F2" idref1="F3"/>
<clue>[Molecular-biologic aspects of <clueType>interaction</clueType> <linkTheme>between</linkTheme> nervous and immune systems]</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The problem of the <term id="T3" lex="neuro-immuno_interaction" sem="Other"><term id="A6" sem="Body_region">neuro</term>-<term id="A7" sem="Body_region">immuno</term> interactions</term> on the level of the <term id="T4" lex="protein_trans-factor" sem="Protein_family_or_group">protein trans-factors</term>, stimulating <term id="T5" lex="interleukin-2_(IL-2)_gene_expression" sem="Other"><term id="T6" lex="interleukin-2_(IL-2)_gene" sem="DNA_domain_or_region"><term id="T7" lex="interleukin-2" sem="Protein_molecule">interleukin-2</term> (<term id="T8" lex="IL-2" sem="Protein_molecule">IL-2</term>) gene</term> expression</term> was discussed.</sentence>
<event KT="Investigation" id="E19" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="T4"/>
<cause idref="E20"/>
<clue>The <clueType>problem</clueType> <linkCause>of</linkCause> the neuro-immuno interactions <linkTheme>on</linkTheme> the level of the protein trans-factors, stimulating interleukin-2 (IL-2) gene expression was <clueKT>discussed</clueKT>.</clue>
<comment>CAUTION, problem</comment></event>
<event KT="Other" id="E20">
<type class="Correlation"/>
<theme idref="A6"/>
<theme idref="A7"/>
<clue>The problem of the neuro-immuno <clueType>interactions</clueType> on the level of the protein trans-factors, stimulating interleukin-2 (IL-2) gene expression was discussed.</clue>
</event>
<event KT="Other" id="E2">
<type class="Gene_expression"/>
<theme idref="T8"/>
<clue>The problem of the neuro-immuno interactions on the level of the protein trans-factors, stimulating interleukin-2 (IL-2) <clueType>gene expression</clueType> was discussed.</clue>
</event>
<event KT="Fact" id="E3">
<type class="Regulation"/>
<theme idref="E2"/>
<cause idref="T4"/>
<clue>The problem of the neuro-immuno interactions on the level of the protein trans-factors, <clueType>stimulating</clueType> interleukin-2 (IL-2) gene expression was discussed.</clue>
</event>
<sentence id="S3">The <cons id="T9" lex="(AND physico-chemical_parameter functional_parameter)" sem="(AND Other Other)"><frag id="F4">physico-chemical</frag> and <frag id="F5">functional</frag> <frag id="F6">parameters</frag></cons> of the <term id="T10" lex="low_molecular_nuclear_protein" sem="Protein_family_or_group">low molecular nuclear proteins</term> (<term id="T11" lex="SP" sem="Protein_family_or_group">SP</term> and <cons id="T12" lex="(AND BP-_14_kD_ BP-_18_kD BP-_19_kD)" sem="(AND Protein_molecule Protein_molecule Protein_molecule)"><frag id="F7">BP-</frag> <frag id="F8">14</frag>, <frag id="F9">18</frag>, <frag id="F10">19</frag> <frag id="F11">kDs</frag></cons>) isolated from <cons id="T13" lex="(AND splenic_cell brain_cell)" sem="(AND Cell_natural Cell_natural)"><frag id="F12">splenic</frag> and <frag id="F13">brain</frag> <frag id="F14">cells</frag></cons> of <term id="T14" lex="immunized_rat" sem="Multicellular_organism_natural">immunized rats</term> were studied.</sentence>
<sentence id="S4">The binding of these proteins to the <term id="A1" sem="DNA_domain_or_region">regulatory region of <term id="T15" lex="IL-2_gene" sem="DNA_domain_or_region">IL-2 gene</term></term> in vitro and stimulation of the <term id="T16" lex="IL-2mRNA_synthesis" sem="Other"><term id="T17" lex="IL-2mRNA" sem="RNA_molecule">IL-2mRNA</term> synthesis</term> in <term id="T18" lex="splenic_T-lymphocyte_culture" sem="Cell_cultured">splenic T-lymphocytes culture</term> in normal conditions were shown.</sentence>
<event KT="Analysis" id="E9" uncertainty="probable">
<type class="Binding"/>
<theme idref="F7" idref1="F8" idref2="F11"/>
<theme idref="A1"/>
<clue>The <clueType>binding</clueType> <linkTheme>of</linkTheme> <corefTheme>these</corefTheme> proteins <linkTheme>to</linkTheme> the regulatory region of IL-2 gene in vitro and stimulation of the IL-2mRNA synthesis in splenic T-lymphocytes culture in normal conditions were <clueKT>shown</clueKT>.</clue>
<comment>TPS: A1</comment></event>
<event KT="Analysis" id="E17">
<type class="Binding"/>
<theme idref="F7" idref1="F9" idref2="F11"/>
<theme idref="A1"/>
<clue>The <clueType>binding</clueType> <linkTheme>of</linkTheme> <corefTheme>these</corefTheme> proteins <linkTheme>to</linkTheme> the regulatory region of IL-2 gene in vitro and stimulation of the IL-2mRNA synthesis in splenic T-lymphocytes culture in normal conditions were <clueKT>shown</clueKT>.</clue>
</event>
<event KT="Analysis" id="E18">
<type class="Binding"/>
<theme idref="F7" idref1="F10" idref2="F11"/>
<theme idref="A1"/>
<clue>The <clueType>binding</clueType> <linkTheme>of</linkTheme> <corefTheme>these</corefTheme> proteins <linkTheme>to</linkTheme> the regulatory region of IL-2 gene in vitro and stimulation of the IL-2mRNA synthesis in splenic T-lymphocytes culture in normal conditions were <clueKT>shown</clueKT>.</clue>
</event>
<event KT="Analysis" id="E10" uncertainty="probable">
<type class="Binding"/>
<theme idref="T11"/>
<theme idref="A1"/>
<clue>The <clueType>binding</clueType> <linkTheme>of</linkTheme> <corefTheme>these</corefTheme> proteins <linkTheme>to</linkTheme> the regulatory region of IL-2 gene in vitro and stimulation of the IL-2mRNA synthesis in splenic T-lymphocytes culture in normal conditions were <clueKT>shown</clueKT>.</clue>
</event>
<event KT="Other" id="E12">
<type class="Transcription"/>
<theme idref="T17"/>
<clue>The binding of these proteins to the regulatory region of IL-2 gene in vitro and stimulation of the IL-2mRNA <clueType>synthesis</clueType> <clueLoc>in splenic T-lymphocytes culture</clueLoc> in normal conditions were shown.</clue>
</event>
<event KT="Analysis" id="E11" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<clue>The binding of these proteins to the regulatory region of IL-2 gene in vitro and <clueType>stimulation</clueType> <linkTheme>of</linkTheme> the IL-2mRNA synthesis in splenic T-lymphocytes culture in normal conditions were <clueKT>shown</clueKT>.</clue>
</event>
<sentence id="S5">The protective effect of <term id="T19" lex="SP" sem="Protein_family_or_group">SP</term> and <term id="T20" lex="BP" sem="Protein_molecule">BP</term> on the <term id="T21" lex="IL-2mRNA_synthesis" sem="Other"><term id="T22" lex="IL-2mRNA" sem="RNA_molecule">IL-2mRNA</term> synthesis</term> in <term id="A5" lex="stressful_condition" sem="Other">stressful conditions</term> and by the <term id="T23" lex="T-cell" sem="Cell_natural">T-cells</term> treatment with the <term id="T24" lex="CsA" sem="Organic_compound_other">CsA</term> was demonstrated.</sentence>
<event KT="Other" id="E5">
<type class="Transcription"/>
<theme idref="T22"/>
<clue>The protective effect of SP and BP on the IL-2mRNA <clueType>synthesis</clueType> in stressful conditions and by the T-cells treatment with the CsA was demonstrated.</clue>
</event>
<event KT="Other" id="E6">
<type class="Negative_regulation"/>
<theme idref="E5"/>
<cause idref="A5"/>
<clue>The protective effect of SP and BP on the IL-2mRNA synthesis <linkCause>in</linkCause> stressful conditions and by the T-cells treatment with the CsA was demonstrated.</clue>
<comment>NO CLUETYPE</comment></event>
<event KT="Method" id="E7">
<type class="Artificial_process"/>
<theme idref="T23"/>
<theme idref="T24"/>
<clue>The protective effect of SP and BP on the IL-2mRNA synthesis in stressful conditions and by the T-cells <clueType>treatment</clueType> <linkTheme>with</linkTheme> the CsA was demonstrated.</clue>
<comment>ARTIFICIAL</comment></event>
<event KT="Other" id="E8">
<type class="Negative_regulation"/>
<theme idref="E5"/>
<cause idref="E7"/>
<clue>The protective effect of SP and BP on the IL-2mRNA synthesis in stressful conditions and <linkCause>by</linkCause> the T-cells treatment with the CsA was demonstrated.</clue>
<comment>NO CLUETYPE</comment></event>
<event KT="Analysis" id="E13">
<type class="Negative_regulation"/>
<theme idref="E6"/>
<cause idref="T19"/>
<clue>The <clueType>protective effect</clueType> <linkCause>of</linkCause> SP and BP <linkTheme>on</linkTheme> the IL-2mRNA synthesis in stressful conditions and by the T-cells treatment with the CsA was <clueKT>demonstrated</clueKT>.</clue>
</event>
<event KT="Analysis" id="E14">
<type class="Negative_regulation"/>
<theme idref="E6"/>
<cause idref="T20"/>
<clue>The <clueType>protective effect</clueType> <linkCause>of</linkCause> SP and BP <linkTheme>on</linkTheme> the IL-2mRNA synthesis in stressful conditions and by the T-cells treatment with the CsA was <clueKT>demonstrated</clueKT>.</clue>
</event>
<event KT="Analysis" id="E15">
<type class="Negative_regulation"/>
<theme idref="E8"/>
<cause idref="T19"/>
<clue>The <clueType>protective effect</clueType> <linkCause>of</linkCause> SP and BP <linkTheme>on</linkTheme> the IL-2mRNA synthesis in stressful conditions and by the T-cells treatment with the CsA was <clueKT>demonstrated</clueKT>.</clue>
</event>
<event KT="Analysis" id="E16">
<type class="Negative_regulation"/>
<theme idref="E8"/>
<cause idref="T20"/>
<clue>The <clueType>protective effect</clueType> <linkCause>of</linkCause> SP and BP <linkTheme>on</linkTheme> the IL-2mRNA synthesis in stressful conditions and by the T-cells treatment with the CsA was <clueKT>demonstrated</clueKT>.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
